[Ip-health] Webcast and final opportunity to register - Medicines for Neglected Diseases Workshop, Boston 10-11 Sept. 2010
mike.gretes at gmail.com
Sun Aug 29 09:17:21 PDT 2010
Only two short weeks away, t
he Medicines for Neglected Diseases Workshop will be held in
Boston 10-11 Sept. 2010 -
immediately before ICAAC 2010 -
web registration closes Sept. 8.
**For those unable to travel to Boston, you may register
for a live, interactive webcast
rofessionals, trainees, and students from low- and
middle-income countries are strongly encouraged to participate, and need pay
only what they can afford - contact MeND2010 at mindthehealthgap.org for more
The Workshop gathers scientists and clinicians in diverse areas of
chemistry, biology, and medicine, along with funders (NIH, Gates
Foundation), health technology product developers (International AIDS
Vaccine Initiative, Drugs for Neglected Diseases initiative, Daktari
Diagnostics, Diagnostics for All), key advocacy organizations and thought
leaders will build consensus on specific
those committed to excellence in biomedical research for people living in
poverty. We will showcase funding, collaboration, and other opportunities
to get involved.
Confirmed media coverage so far includes Nature (Editor), Nature
Editor), and Chemical & Engineering News (Editor). Key speakers and t
hree panels will focus on key considerations for the development of
therapeutics, vaccines and diagnostics for people living in low-income
Keynote Address: Thomas Pogge, President & Director, Incentives for Global
Health; Leitner Professor of Philosophy & International Affairs at Yale
University; Professorial Fellow, ANU Centre for Applied Philosophy & Public
Opening Remarks: Ashley Stevens, President, Association for University
Special Workshop Session: Barry Bunin, Chief Executive Officer,
Collaborative Drug Discovery.
Panel 1: Priorities & Pathways to Affordable Drugs, Diagnostics &
- Els Torreele – Project Director, Access to Medicines Initiative, Open
Society Institute; past Senior Project Manager, Drugs for Neglected Diseases
initiative; past Coordinator, Drugs for Neglected Diseases Working Group at
Médecins Sans Frontières/Doctors without Borders.
- Dennis Liotta – Professor of Chemistry, Emory University; Director,
Emory Institute for Drug Discovery.
- James Love – Director, Knowledge Ecology International.
- Jerrold Ellner – Professor & Chief, Division of Infectious Diseases,
Boston University School of Medicine, Boston Medical Center; Principal
Investigator, NIH Clinical Diagnostics Research Consortium for TB.
2: Collaborations with Industry & Product Development Partnerships
- David Cook – Executive Vice President & Chief Operating Officer,
International AIDS Vaccine Initiative; past Chief Executive Officer, Anza
- Una Ryan – President & Chief Executive Officer, Diagnostics for All.
- Denice Spero – Co-director, Institute of Immunology & Informatics,
Providence, RI; Research Professor, University of Rhode Island; Co-founder,
Developing World Cures; past Vice President Drug Discovery,
- Jean-Pierre Paccaud – Business Development Director, Drugs for
Neglected Diseases initiative (DNDi).
- Melinda Moree – Chief Executive Officer, BIO Ventures for Global
Health; past Chief Executive Officer, PATH Malaria Vaccine Initiative.
Panel 3: Funding Sources, Trends & Policy Proposals
- William Rodriguez – Founder, Daktari Diagnostics; past Chief Medical
Officer, Clinton Foundation.
- Javier Guzman – Director of Research, Policy Cures; Co-Author, G-
FINDER Neglected Diseases Funding Report Series.
- John Rogers – Preclinical Parasite Drug Development Program Officer,
Parasitology & International Programs Branch, National Institute of Allergy
& Infectious Diseases, NIH.
- Neil McDonnell – Chief of Staff, Global Health Program, Bill & Melinda
- Kevin Outterson – Associate Professor of Law, Boston University;
Chief, Journal of Law, Medicine & Ethics.
The Workshop flyer is attached - please feel free to get in touch with me if
you have any questions, and feel free to pass this information around to
On Mon, Jun 21, 2010 at 8:50 AM, Outterson, Michael Kevin <mko at bu.edu>wrote:
> Registration for the 10-11 Sept. 2010 Neglected Diseases Workshop in Boston
> (co-presented by BU Law and UAEM Chapters at BU, Harvard and MIT) is now
> open! Kindly spread the word, especially among biomedical researchers, and
> I hope you'll consider attending yourselves. The Workshop occurs
> immediately before ICAAC.
> Kevin Outterson
> Associate Professor of Law & Co-Director of the Health Law Program
> Boston University School of Law
> Associate Professor of Health Law, Bioethics, and Human Rights
> Boston University School of Public Health
> Editor in Chief - Journal of Law, Medicine & Ethics
> Faculty Advisor - American Journal of Law & Medicine
> Academic papers at: www.ssrn.com/author=340746
> 617 353 3103 w
> Ip-health mailing list
> Ip-health at lists.keionline.org
Mike Gretes, PhD (Biochemistry)
Medicines for Neglected Diseases (MeND) Workshop
Boston 10-11 Sept. 2010
More information about the Ip-health